We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually

By LabMedica International staff writers
Posted on 20 Oct 2020
Print article
Image: Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually (Photo courtesy of Mindray)
Image: Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually (Photo courtesy of Mindray)
Image: The customized Mindray CAL 8000 automation lines help the lab improve workflow and reduce manual handling (Photo courtesy of Mindray)
Image: The customized Mindray CAL 8000 automation lines help the lab improve workflow and reduce manual handling (Photo courtesy of Mindray)
Image: Routes optimisation - Regular design and sample route (Photo courtesy of Mindray)
Image: Routes optimisation - Regular design and sample route (Photo courtesy of Mindray)
Image: Routes optimisation - Customized design and sample route(Photo courtesy of Mindray)
Image: Routes optimisation - Customized design and sample route(Photo courtesy of Mindray)
High-volume laboratories face several challenges, including high instrument failure rate, errors due to several manual steps, low efficiency and long TAT, and heavier workload for the lab staff.

Mindray’s (Shenzhen, China) hematology solutions can help labs face these challenges such as its tailor-made solution provided for CientíficaLab (Sao Paulo, Brazil) that now helps the high-volume lab run 2,820,000 CBC tests annually.

Owned by one of the largest diagnostic laboratory chains in the world, CientíficaLab provides clinical analysis service to 26 hospitals and 883 outpatient units in the Brazil public sector. Prior to its recent partnership with Mindray, CientíficaLab used to perform all its blood tests on more than a dozen stand-alone analyzers and slide makers, which were low in efficiency and demanded significant manpower. With overwhelming workload, the laboratory staff had to work extremely long hours, with three shifts a day, six days a week. High failure rate of the old instruments posed another daunting challenge for CientíficaLab, often resulting in extensive downtime.

After studying the laboratory’s challenges, Mindray came up with a tailor-made hematology automation solution for CientíficaLab. To automate its workflow and improve productivity, Mindray replaced the old stand-alone instruments with two high performance CAL 8000 Cellular Analysis Lines, each connecting four units of BC-6800Plus Auto Hematology Analyzers and one unit of SC-120 Auto Slide Maker and Stainer. Equipped with the labXpert data analysis software, the automation lines automatically validate test results and perform rerun and retest of abnormal hematology samples as per pre-defined rules. This helped reduce the laboratory's manual work substantially and improve its Standard Operating Procedures (SOPs).

After tracking the laboratory’s working path of samples, from collection to testing to microscopic analysis, Mindray provided a customized solution – placing the two automation lines face-to-face, but re-configuring one of them to make its sample route in the same direction as the other. This special design now enables just one technician to easily handle large amount of samples on both lines at the same time creating the shortest, most time-saving route from sample loading to unloading, all the way to microscopic review and result delivery.

During onsite inspection, Mindray discovered another possibility of helping CientíficaLab optimize its workflow. Before installing CAL 8000, the laboratory technicians had to print out the test result of the abnormal sample, and then bring the result along with the slide to the microscopy area for result comparison. These paper documents will be filed away for five years, managing which will be a demanding task. Mindray helped digitalize the process by installing the labXpert software at the microscopy area which allows data transfer and storage within the laboratory information system. Simply by scanning the barcode on the slides, technicians can now easily access the information of the test results during microscopic analysis.

Higher stability and reliability of the CAL 8000 system have also brought significant benefits for CientíficaLab in terms of enhanced efficiency and faster TAT. The laboratory used to have 11 stand-alone instruments that always had breakdown issues, with uptime of only around 60% to 70%. CientíficaLab had to wait for engineers to repair or spare parts to be sent which could take days and significantly impacted daily routine. The introduction of CAL 8000 with its reliability and stability has been a gift for the laboratory. Mindray analyzers rarely see any failure issues which are resolved on the very same day or no later than the next day by the company or its local distributor.

With the introduction of the two customized CAL 8000, CientíficaLab has achieved significant improvement in both production capacity and cost-effectiveness. With the full capacity of just one CAL 8000 being superior to the previous 11 instruments operated by CientíficaLab and two Mindray automation lines working in good condition, there has been a huge improvement in the lab’s performance. Today, CientíficaLab’s headquarters alone performs 3,000,000 different tests per month, with up to 9,000 hematology tests each day – totaling nearly 2,820,000 a year.

“With the introduction of CAL 8000, we have increased our testing capacity,” said Fabiana Gomes Lancelotti, Hematology Department Supervisor at CientíficaLab. “The SC-120 Slide Maker and Stainer makes slides for microscopic analysis, then the results will be automatically validated and ready to report.”

“By placing one CAL 8000 face-to-face with the other, and adjusting the sample routes in the same direction, we can reduce the number of staff and make the process much simpler. Our productivity has improved by 50%,” said Audrei Roberto Bertini, Production Manager at CientíficaLab.

Related Links:

Mindray
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.